Oral β-Lactam Antibiotics for Pediatric Otitis Media, Rhinosinusitis, and Pneumonia.
Administration, Oral
Cephalosporins
/ administration & dosage
Child
Humans
Otitis Media
/ drug therapy
Penicillins
/ administration & dosage
Pneumonia, Pneumococcal
/ drug therapy
Rhinitis
/ drug therapy
Sinusitis
/ drug therapy
Streptococcus pneumoniae
/ drug effects
beta-Lactams
/ administration & dosage
Amoxicillin
beta-lactams
pharmacokinetics
Journal
Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners
ISSN: 1532-656X
Titre abrégé: J Pediatr Health Care
Pays: United States
ID NLM: 8709735
Informations de publication
Date de publication:
Historique:
received:
26
11
2018
revised:
29
10
2019
accepted:
06
11
2019
entrez:
27
4
2020
pubmed:
27
4
2020
medline:
29
6
2021
Statut:
ppublish
Résumé
Acute otitis media, acute bacterial rhinosinusitis, and community-acquired pneumonia are major drivers of pediatric antibiotic consumption. With many available options and the added challenges of navigating antibiotic allergies and de-escalating from intravenous treatment for children requiring hospitalization, prescribing for these relatively simple infections can be a source of confusion and error. The purpose of this article is to evaluate the pharmacokinetic and pharmacodynamic properties of antibiotics commonly prescribed for these disease states, and to specifically compare antipneumococcal activity between oral beta-lactams.
Identifiants
pubmed: 32334748
pii: S0891-5245(18)30654-0
doi: 10.1016/j.pedhc.2019.11.001
pii:
doi:
Substances chimiques
Cephalosporins
0
Penicillins
0
beta-Lactams
0
Types de publication
Journal Article
Review
Langues
eng
Pagination
291-300Informations de copyright
Copyright © 2019 National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.